Stocks and Investing Stocks and Investing
Tue, August 4, 2020
Mon, August 3, 2020

Vamil Divan Maintained (ABBV) at Strong Buy with Increased Target to $111 on, Aug 3rd, 2020


Published on 2024-10-27 11:22:03 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Mizuho, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $110 to $111 on, Aug 3rd, 2020.

Vamil has made no other calls on ABBV in the last 4 months.



There are 6 other peers that have a rating on ABBV. Out of the 6 peers that are also analyzing ABBV, 1 agrees with Vamil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jason Gerberry of "B of A Securities" Initiated at Hold and Held Target at $95 on, Monday, May 18th, 2020


These are the ratings of the 5 analyists that currently disagree with Vamil


  • Steve Chesney of "Atlantic Equities" Upgraded from Hold to Buy and Held Target at $115 on, Tuesday, June 23rd, 2020
  • Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Wednesday, June 17th, 2020
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $115 on, Tuesday, June 2nd, 2020
  • David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $95 on, Monday, May 11th, 2020
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Monday, May 11th, 2020
Contributing Sources